Article
Integrating Immune Multi-Omics and Machine Learning to Improve Prognosis, Immune Landscape, and Sensitivity to First- and Second-Line Treatments for Head and Neck Squamous Cell Carcinoma
2024-07-26
Abstract excerpt
<title>Abstract</title> <p><bold>Background: </bold>In recent years, immune checkpoint inhibitors (ICIs) has emerged as a fundamental component of the standard treatment regimen for patients with head and neck squamous cell carcinoma (HNSCC). However, accurately predicting the treatment effectiveness of ICIs for patients at the same TNM stage remains a challenge. <bold>Methods: </bold>In this study, we first comb...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 54f4fea6-d6ee-5aa6-b274-76b4507ff0bc
- DOI
- 10.21203/rs.3.rs-4659367/v1
